The Chief Medical Officer of Health in Nova Scotia has expanded eligibility for publicly funded RSV immunization to adults 75+, infants under 8 months entering their first RSV season, and high-risk infants under 2. Starting this Fall, these groups can receive the vaccine or monoclonal antibodies free of charge with a valid NS health card. In this episode, PANS’ Suzanne Richards catches up with Dr. Tasha Ramsey, the Nova Scotia Health (NSH) Clinical Therapeutics and Prophylactics Lead for Emerging and Re-Emerging Infections, to discuss the program update and the vaccine. They will discuss who is eligible for the immunization agents, why preventing RSV in certain demographics is important, and review the recommendations for pregnant individuals & infants. Tasha will explain where eligible patients can access the publicly funded supply and whic ...